EDGAR·FLOW

ACCENDRA HEALTH INC/VA/ — Form 8-K

Filed November 17, 2026 · analyzed by the 8-K Agent
8-K ▼ Likely negative significance 72/100
What the filing says
On November 16, 2026, the NYSE notified Accendra Health that it would delist the company's common stock due to abnormally low selling prices under NYSE Rule 802.01D. Trading moved to the OTCQB market under ticker 'ACCH' on November 17, 2026. The company states the transition does not affect operations or SEC reporting obligations, nor trigger defaults under material debt agreements.
Why this rating

NYSE delisting is a material reputational and operational event for a $677.5M company—reduces liquidity, investor access, and signals distress, though operations continue unchanged.

Tradability signal
NO TRADE

No trade: price $0.09 is below our $0.5 floor — spreads at this level eat any edge. (Filing arrived outside market hours — evaluated at the next open with a live quote.)

Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.

Price action (we called it negative)
at our read · unknown
$0.09
+10 min · unknown
$0.09 ▲ 0.00%
+30 min · unknown
$0.09 ▲ 0.00%
+1 hr · unknown
$0.09 ▲ 0.00%
+4 hrs · unknown
$0.09 ▲ 0.00%

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ ACH · stock on Yahoo Finance ↗

See more from November 17, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.